Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Diabetes|December 1, 1996
Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulinN S Fineberg, S E Fineberg, J H Anderson, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1988
Effect of insulin immune complexes on human blood monocyte and endothelial cell procoagulant activityB Uchman, N U Bang, M J Rathbun, et al.
Diabetes|February 1, 1984
Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathyR P Lamberton, A D Goodman, A Kassoff, et al.
Neurology|July 10, 2002
Effects of admission hyperglycemia on mortality and costs in acute ischemic strokeL S Williams, J Rotich, R Qi, et al.
Diabetes Care|October 17, 1998
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin InterventionsM A Espeland, P E Hogan, S E Fineberg, et al.
Diabetes Care|November 1, 1982
Clinical pharmacologic studies with human insulin (recombinant DNA)J A Galloway, M A Root, R Bergstrom, et al.
Diabetes Care|November 1, 1982
The U.S. "new patient" and "transfer" studiesJ A Galloway, F B Peck, S E Fineberg, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1989
Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acidW L Lowe, C T Roberts, D LeRoith, et al.
Diabetes Care|August 1, 1992
Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient populationD G Marrero, J L Vandagriff, R Gibson, et al.
Diabetes|March 1, 1988
Immunologic aspects of human proinsulin therapyS E Fineberg, M J Rathbun, S Hufferd, et al.
Pageof 10